Skip to main content
TipRanks
Go Ultimate75% OFF
Aurenar logo

Aurenar: Valuation, Funding & Investors

Aurenar develops a first-in-class, non-invasive, single-use neuromodulation platform designed to reduce life-threatening complications in intensive care unit patients. Its technology focuses on improving outcomes for stroke and other acute neurological conditions in ICU settings by providing scalable, bedside neuromodulation therapy.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$6M
Total Funding Rounds
1
Latest Funding Amount
$6M
Latest Funding Round
Seed Round

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Jul 28, 2026Seed Round$5.70M―

Investors

Investor NameFunding Round
Go Red for Women Venture FundSeed Round
Solas BioVenturesSeed Round
BJC HealthSeed Round
Kaleida CapitalSeed Round

Similar Companies

A snapshot of private companies similar to Aurenar, helping you discover and navigate related company profiles.

Related News and Analysis